ArticleJournal of neurosurgery. Case lessons2026
Life-threatening intraparenchymal hematoma due to immune thrombocytopenic purpura: illustrative case.
Article in Journal of neurosurgery. Case lessons, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLife-threatening intraparenchymal hematoma (IPH) is an uncommon yet challenging complication of immune thrombocytopenia (ITP) in adults. OBSERVATIONS: A 26-year-old man with a history of medically refractory chronic ITP experienced abrupt neurological deterioration due to a large left frontal IPH. His platelet count was 8 × 103/μL. Following the administration of high-dose dexamethasone, intravenous immunoglobulin (IVIG), and platelet transfusions, an emergency craniotomy and hematoma evacuation were performed. After surgery, the patient regained consciousness, and his platelet levels initially improved. The patient was advised to undergo an elective splenectomy within a week as a definitive measure for ITP; however, his platelet count dropped to 9 × 103/μL by day 6 postsurgery. An urgent splenectomy was performed, resulting in an immediate as well as long-term improvement in platelet count. LESSONS: This case highlights critical lessons in the management of IPH secondary to ITP. In the event of life-threatening IPH, emergency craniotomy and hematoma evacuation are necessary. Platelet support is achieved through transfusion, IVIG, and steroids. Splenectomy should be performed as soon as feasible following the evacuation of a hematoma to prevent the recurrence of thrombocytopenia, which may result in rebleeding. Collaboration among neurosurgeons, hematologists, and intensivists is key to a satisfactory outcome. https://thejns.org/doi/10.3171/CASE25394.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.